Arrowhead price target lowered to $17 from $21 at Citi

Citi lowered the firm’s price target on Arrowhead (ARWR) to $17 from $21 and keeps a Neutral rating on the shares. The company reported fiscal Q2 financial results and gave progress updates on its “extensive” pipeline of over 15 assets in development, the analyst tells investors in a research note. The firm says that while the decision to pay down some of its credit facility will be seen positively by some investors, it still sees a “low ceiling for shares” in the short term due to limited upside for the familial chylomicronemia syndrome launch.